Rheinmetall's Waiting Game: A Record Order Book, a Sliding Share Price, and a Market Demanding Proof

Rheinmetall shares fall 3% to €1,018.40, down a third this year, despite record orders and 69% sales growth, as delivery delays and budget fears weigh.

The arithmetic of Rheinmetall's current predicament is stark. The Düsseldorf-based defence group ended Wednesday's session at €1,018.40, down 3.0 percent on the day, leaving the stock roughly a third below its value at the start of the year. Yet this is a company sitting on an order backlog of €80.5 billion, fresh off a quarter in which sales jumped 69 percent. The disconnect between the balance sheet and the share price has rarely been wider—and investors are increasingly asking which number tells the truth.

What makes the current slide particularly uncomfortable for shareholders is the absence of a single, clean catalyst. The stock has been drifting lower since early August, and Wednesday's decline came with no specific news attached. Chart watchers note the shares now trade 7.2 percent below their 50-day moving average, a technical signal that the near-term trend has deteriorated. From the October 3, 2025 peak of €2,007.00, the stock has surrendered roughly 48 percent of its value.

Delivery Delays and a Trimmed Outlook

Part of the damage is self-inflicted. In August, the Bundeswehr publicly criticised Rheinmetall over delays in two flagship programmes, a rare rebuke from its most important customer. The Skyranger 30 air-defence platform will now begin deliveries in mid-2027 rather than mid-2026—a twelve-month slip. On the Heavy Weapons Carrier Infantry programme, the military cites an eleven-month delay; Rheinmetall disputes that characterisation. The Bundeswehr's complaint referenced "insufficient maturity and quality" of the systems involved.

The criticism landed just as the company delivered numbers that, on the surface, looked spectacular. Second-quarter revenue climbed 69 percent to €3,289 million, with operating profit up 115 percent to €562 million. The operating margin expanded to 17.1 percent from 13.4 percent a year earlier. Yet management simultaneously trimmed its full-year revenue guidance to €13.7–14.2 billion from a previous €14.0–14.5 billion, and disclosed a first-half free cash flow of minus €1,616 million. On the day of the release, the shares fell as much as 8.5 percent despite the record quarter—a telling sign that the market was focused on the trajectory, not the snapshot.

Berlin's Budget Debate Adds a Political Layer

If delivery delays are the operational headache, politics supplies the strategic one. Media reports of possible cuts to German ammunition spending from 2027 have injected a fresh dose of anxiety into the stock. For a company whose growth narrative rests so heavily on expanding European defence budgets, the mere discussion of future reductions—even if nothing has been decided—carries outsized weight. The debate is being cited as one of the key overhangs on the share price, compounding the operational concerns.

The timing is awkward. Rheinmetall is simultaneously trying to position itself as a transatlantic player, and the US side of the business continues to generate steady, if modest, wins. The U.S. Navy has ordered spare parts for mobile air-start units in a low-single-digit million euro deal, following a September 2 contract under which American Rheinmetall will supply machined components for MCT-30 turrets to Kongsberg Defence & Aerospace, worth around $710,000, with production in Lapeer and Lansing and deliveries slated for 2026 and 2027. Individually, these contracts are small; collectively, they underscore a deepening American footprint, alongside the handover of the first Lynx XM30 prototype to the U.S. Army and a planned €270 million investment to expand the Kassel site into a tank and logistics hub.

The Arminius Prize

The bigger prize, however, remains in Europe. Final negotiations for the so-called Arminius order—a Boxer vehicle programme with a firm order worth around €25 billion, of which Rheinmetall's share is €12.4 billion—are scheduled for this week. The associated framework agreement could reach as much as €75 billion. Parliamentary review in the Bundestag is planned for December, with contract signature potentially following shortly after.

Smaller domestic contracts continue to trickle in as well: the Bundeswehr has ordered 23 Büffel armoured recovery vehicles worth over €500 million.

Analysts Hold the Line, For Now

Sell-side consensus has remained remarkably stable through the turbulence. Eleven houses average a price target of €1,700, with a range spanning €1,060 to €2,415, and 86 percent of ratings at Buy. The outlier is MWB Research, which on September 2 upgraded the stock from Sell to Hold—but set a target of €1,050.00, essentially at the current price, suggesting a more cautious view that weights near-term headwinds more heavily.

Management will have opportunities to make its case in the coming days, with appearances scheduled at the Bernstein 23rd Annual Pan-European Conference and the Jefferies Industrials Conference. The hope among investors is that executives will address the munitions debate head-on and offer clarity on the order pipeline. Whether words will be enough to close the gap between a record order book and a share price that keeps sliding remains the central question. For now, the market seems to be saying that in defence, as in any industry, promises are cheap—execution is everything.